Journal
JOURNAL OF AFFECTIVE DISORDERS
Volume 233, Issue -, Pages 36-44Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jad.2017.08.087
Keywords
-
Categories
Funding
- NARSAD Distinguished Investigator Award
- Canadian Institute of Health Research (CIHR) [FDN148374, EGM141899]
- FRQS through the Quebec Network on Suicide, Mood Disorders and Related Disorders
Ask authors/readers for more resources
Background: Antidepressant treatment is associated with a high rate of poor response, and thus, biomarker development is warranted. Methods: We aimed to synthesize studies investigating gene expression, small RNAs, and epigenomic biomarkers of antidepressant response. We conducted a narrative review of the literature. Results: Firstly, we detailed the challenges involved, in terms of biological tissues, relevant study time frames, and mandatory statistical tools. Secondly we synthesized results obtained in gene expression studies, focusing mainly on genome-wide studies, particularly small non-coding RNA, including micro-RNA and other small RNA species. In addition, we reviewed the potential biomarkers of antidepressant response arising from studies investigating DNA methylation variation and histone modifications. Limitations: We did not conduct a meta-analysis due to the heterogeneity of the study. Conclusion: Although promising, the field of gene expression and epigenomic biomarkers of antidepressant response is still in its infancy, and needs further development to define useful biomarkers in clinical practice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available